Answers are grounded in this paper and cite their sources.
Quality improvement study demonstrates enhanced preparedness for diabetes management in pediatric post-TPIAT patients, suggesting effective educational interventions.
Introduction and Objective: Total pancreatectomy with islet autotransplantation (TPIAT) requires families to manage diabetes with insulin pumps and continuous glucose monitors post-operatively at our institution. We created a structured pre-TPIAT diabetes education program that used condition-specific content to increase the primary learner’s preparedness for post-surgical diabetes management and improve the efficiency of subsequent inpatient education. Methods: This quality improvement study analyzed 33 pediatric TPIAT recipients at Cincinnati Children’s who received structured pre-surgery education across three Plan-Do-Study-Act (PDSA) cycles. Data were extracted from clinical records and survey responses collected. Qualitative survey data were collected from Cycle 3 participants only. Results: The cohort was predominantly White (87.9%), non-Hispanic (97.0%), with balanced sex distribution (48.5% female). Mean age at surgery was 12.2 years. Parents served as primary learners in 87.9% of cases. Pre-surgery education time showed highly statistically significant increases in Cycles 2 and 3 compared to Cycle 1 (p=0.0291 and p=0.0007, respectively). Basic inpatient diabetes education time showed a marginally significant decrease from Cycle 1 to Cycle 2 (p=0.0717) which was maintained in Cycle 3 (0.3285). Survey results demonstrated substantial knowledge acquisition from the education intervention. Conclusion: Changes in TPIAT diabetes education delivery were implemented and improved technical knowledge. A modest decrease in inpatient diabetes education time was documented from cycle 1 to cycles 2 and 3. Future confirmatory studies will validate the knowledge gains observed in this pilot. Next steps include assessing longer-term knowledge retention and incorporating stress management into education sessions. Disclosure S. Tellez: None. C. Fox: None. A.K. Essell: None. L. Lin: None. M. Abu El Haija: None. D.A. Elder: Research Support; Current; Sanofi.
No takes yet. Share an insight, caveat, or question.
Tellez et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: